Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padmanee Sharma

Showing results (41-50 of 216) with videos related to

Pageof 22
Sort By:
Advances in Experimental Medicine and Biology|December 13, 2018
Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical PracticeLucia Masarova, Hagop Kantarjian, Farhad Ravandi, et al.
The Journal of Experimental Medicine|April 2, 2014
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapyXiaozhou Fan, Sergio A Quezada, Manuel A Sepulveda, et al.
Annual Review of Medicine|October 25, 2012
Harnessing the power of the immune system to target cancerGregory Lizée, Willem W Overwijk, Laszlo Radvanyi, et al.
Journal for Immunotherapy of Cancer|June 3, 2014
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primerRaju R Raval, Andrew B Sharabi, Amanda J Walker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSFPadmanee Sharma, Dean F Bajorin, Achim A Jungbluth, et al.
Cell|November 16, 2019
Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint TherapyShiping Jiao, Sumit K Subudhi, Ana Aparicio, et al.
Clinical Chemistry|May 19, 2017
The Phoenix Rises: The Rebirth of Cancer ImmunotherapyIvan M Blasutig, Sofia Farkona, Elizabeth I Buchbinder, et al.
Nature Reviews. Immunology|June 19, 2026
Programming the immunological properties of mRNA vaccines for cancerAnnette Wu, Seong Dong Jeong, Benjamin R Schrank, et al.
Leukemia|March 1, 2018
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromesNaval Daver, Prajwal Boddu, Guillermo Garcia-Manero, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibodyMehmet Asim Bilen, Sumit K Subudhi, Jianjun Gao, et al.
Pageof 22

Showing results (41-50 of 216) with videos related to

Sort By:
Pageof 22
Advances in Experimental Medicine and Biology|December 13, 2018
Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical PracticeLucia Masarova, Hagop Kantarjian, Farhad Ravandi, et al.
The Journal of Experimental Medicine|April 2, 2014
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapyXiaozhou Fan, Sergio A Quezada, Manuel A Sepulveda, et al.
Annual Review of Medicine|October 25, 2012
Harnessing the power of the immune system to target cancerGregory Lizée, Willem W Overwijk, Laszlo Radvanyi, et al.
Journal for Immunotherapy of Cancer|June 3, 2014
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primerRaju R Raval, Andrew B Sharabi, Amanda J Walker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSFPadmanee Sharma, Dean F Bajorin, Achim A Jungbluth, et al.
Cell|November 16, 2019
Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint TherapyShiping Jiao, Sumit K Subudhi, Ana Aparicio, et al.
Clinical Chemistry|May 19, 2017
The Phoenix Rises: The Rebirth of Cancer ImmunotherapyIvan M Blasutig, Sofia Farkona, Elizabeth I Buchbinder, et al.
Nature Reviews. Immunology|June 19, 2026
Programming the immunological properties of mRNA vaccines for cancerAnnette Wu, Seong Dong Jeong, Benjamin R Schrank, et al.
Leukemia|March 1, 2018
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromesNaval Daver, Prajwal Boddu, Guillermo Garcia-Manero, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibodyMehmet Asim Bilen, Sumit K Subudhi, Jianjun Gao, et al.
Pageof 22